Allergic fungal rhinosinusitis-Surgical management

Raghu S. Athre, Bradley F. Marple

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The term allergic fungal rhinosinusitis (AFRS) has been used to describe a clinicopathological entity characterized by: Nasal polyposis Crust formation Atopy Sinus cultures with fungus present Lack of tissue invasion on pathological analysis [25] Safi rstein [33] fi rst recognized the similarity between this entity and allergic bronchopulmonary aspergillosis in 1976. Since that time, a great deal of research has been devoted to the understanding, pathophysiology, and treatment of this disease. Despite these eff orts, a large number of questions still remain unanswered and serve as the nidus for future clinical research. The presence of fungus within the paranasal sinuses has a broad range of ramifi cations, ranging from the benign presence of saprophytic fungal growth to invasive fungal rhinosinusitis. The presence of fungus on cultures, the AFRS hallmarks of bony expansion, and radiological evidence of invasion led many clinicians to believe that AFRS was an early stage on the spectrum of invasive fungal rhinosinusitis [12, 25]; hence, an aggressive surgical stance was adopted as the primary mode of management of AFRS. Mc-Guirt and Harrill [30] stated in 1979, "Without question, the treatment of paranasal sinus aspergillosis is surgical-the key to successful surgical treatment is the removal of diseased mucosa and aeration and drainage of the involved sinus." Such evidence urged surgeons to perform radical surgeries such as lateral rhinotomies, craniofacial resections, and facial degloving procedures to extirpate the diseased mucosa [26]. In 1988, Sarti et al. [34] reported a case of paranasal sinus aspergillosis that exhibited expansion into the anterior cranial fossa and sella turcica. The patient was treated with a craniofacial resection, and unfortunately died secondary to a pulmonary embolus in the postoperative period. However, on fi nal pathological examination, no evidence of tissue invasion was noted. Numerous studies have subsequently shown AFRS to be a separate clinical entity from invasive fungal rhinosinusitis and have implicated atopy as one of the causative factors. Manning and Holman [23] showed that in vitro and in vivo allergy to fungal antigens were important to the pathophysiology of AFRS and that the predominance of eosinophil-derived infl ammatory mediators in in vivo tissue specimens diff erentiated AFRS from other forms of chronic rhinosinusitis. These studies gave further credence to the fact that AFRS is an immunological disease rather than an entity on the spectrum of infectious/invasive fungal disease. The change in mindset from invasive disease to immunologically based disease has altered the treatment algorithms for AFRS from that of extensive surgery and antifungal therapy to mucosa-sparing surgery with adjunctive corticosteroids [25].

Original languageEnglish (US)
Title of host publicationRhinologic and Sleep Apnea Surgical Techniques
PublisherSpringer Berlin Heidelberg
Pages111-117
Number of pages7
ISBN (Print)9783540340195
DOIs
StatePublished - 2007

Fingerprint

Paranasal Sinuses
Mucous Membrane
Fungi
Aspergillosis
Fungal Antigens
Anterior Cranial Fossa
Allergic Bronchopulmonary Aspergillosis
Sella Turcica
Therapeutics
Mycoses
Immune System Diseases
Embolism
Nose
Research
Postoperative Period
Eosinophils
Cations
Drainage
Adrenal Cortex Hormones
Hypersensitivity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Athre, R. S., & Marple, B. F. (2007). Allergic fungal rhinosinusitis-Surgical management. In Rhinologic and Sleep Apnea Surgical Techniques (pp. 111-117). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-34020-1_11

Allergic fungal rhinosinusitis-Surgical management. / Athre, Raghu S.; Marple, Bradley F.

Rhinologic and Sleep Apnea Surgical Techniques. Springer Berlin Heidelberg, 2007. p. 111-117.

Research output: Chapter in Book/Report/Conference proceedingChapter

Athre, RS & Marple, BF 2007, Allergic fungal rhinosinusitis-Surgical management. in Rhinologic and Sleep Apnea Surgical Techniques. Springer Berlin Heidelberg, pp. 111-117. https://doi.org/10.1007/978-3-540-34020-1_11
Athre RS, Marple BF. Allergic fungal rhinosinusitis-Surgical management. In Rhinologic and Sleep Apnea Surgical Techniques. Springer Berlin Heidelberg. 2007. p. 111-117 https://doi.org/10.1007/978-3-540-34020-1_11
Athre, Raghu S. ; Marple, Bradley F. / Allergic fungal rhinosinusitis-Surgical management. Rhinologic and Sleep Apnea Surgical Techniques. Springer Berlin Heidelberg, 2007. pp. 111-117
@inbook{5a5f665b0786401780f3993057fc03c0,
title = "Allergic fungal rhinosinusitis-Surgical management",
abstract = "The term allergic fungal rhinosinusitis (AFRS) has been used to describe a clinicopathological entity characterized by: Nasal polyposis Crust formation Atopy Sinus cultures with fungus present Lack of tissue invasion on pathological analysis [25] Safi rstein [33] fi rst recognized the similarity between this entity and allergic bronchopulmonary aspergillosis in 1976. Since that time, a great deal of research has been devoted to the understanding, pathophysiology, and treatment of this disease. Despite these eff orts, a large number of questions still remain unanswered and serve as the nidus for future clinical research. The presence of fungus within the paranasal sinuses has a broad range of ramifi cations, ranging from the benign presence of saprophytic fungal growth to invasive fungal rhinosinusitis. The presence of fungus on cultures, the AFRS hallmarks of bony expansion, and radiological evidence of invasion led many clinicians to believe that AFRS was an early stage on the spectrum of invasive fungal rhinosinusitis [12, 25]; hence, an aggressive surgical stance was adopted as the primary mode of management of AFRS. Mc-Guirt and Harrill [30] stated in 1979, {"}Without question, the treatment of paranasal sinus aspergillosis is surgical-the key to successful surgical treatment is the removal of diseased mucosa and aeration and drainage of the involved sinus.{"} Such evidence urged surgeons to perform radical surgeries such as lateral rhinotomies, craniofacial resections, and facial degloving procedures to extirpate the diseased mucosa [26]. In 1988, Sarti et al. [34] reported a case of paranasal sinus aspergillosis that exhibited expansion into the anterior cranial fossa and sella turcica. The patient was treated with a craniofacial resection, and unfortunately died secondary to a pulmonary embolus in the postoperative period. However, on fi nal pathological examination, no evidence of tissue invasion was noted. Numerous studies have subsequently shown AFRS to be a separate clinical entity from invasive fungal rhinosinusitis and have implicated atopy as one of the causative factors. Manning and Holman [23] showed that in vitro and in vivo allergy to fungal antigens were important to the pathophysiology of AFRS and that the predominance of eosinophil-derived infl ammatory mediators in in vivo tissue specimens diff erentiated AFRS from other forms of chronic rhinosinusitis. These studies gave further credence to the fact that AFRS is an immunological disease rather than an entity on the spectrum of infectious/invasive fungal disease. The change in mindset from invasive disease to immunologically based disease has altered the treatment algorithms for AFRS from that of extensive surgery and antifungal therapy to mucosa-sparing surgery with adjunctive corticosteroids [25].",
author = "Athre, {Raghu S.} and Marple, {Bradley F.}",
year = "2007",
doi = "10.1007/978-3-540-34020-1_11",
language = "English (US)",
isbn = "9783540340195",
pages = "111--117",
booktitle = "Rhinologic and Sleep Apnea Surgical Techniques",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Allergic fungal rhinosinusitis-Surgical management

AU - Athre, Raghu S.

AU - Marple, Bradley F.

PY - 2007

Y1 - 2007

N2 - The term allergic fungal rhinosinusitis (AFRS) has been used to describe a clinicopathological entity characterized by: Nasal polyposis Crust formation Atopy Sinus cultures with fungus present Lack of tissue invasion on pathological analysis [25] Safi rstein [33] fi rst recognized the similarity between this entity and allergic bronchopulmonary aspergillosis in 1976. Since that time, a great deal of research has been devoted to the understanding, pathophysiology, and treatment of this disease. Despite these eff orts, a large number of questions still remain unanswered and serve as the nidus for future clinical research. The presence of fungus within the paranasal sinuses has a broad range of ramifi cations, ranging from the benign presence of saprophytic fungal growth to invasive fungal rhinosinusitis. The presence of fungus on cultures, the AFRS hallmarks of bony expansion, and radiological evidence of invasion led many clinicians to believe that AFRS was an early stage on the spectrum of invasive fungal rhinosinusitis [12, 25]; hence, an aggressive surgical stance was adopted as the primary mode of management of AFRS. Mc-Guirt and Harrill [30] stated in 1979, "Without question, the treatment of paranasal sinus aspergillosis is surgical-the key to successful surgical treatment is the removal of diseased mucosa and aeration and drainage of the involved sinus." Such evidence urged surgeons to perform radical surgeries such as lateral rhinotomies, craniofacial resections, and facial degloving procedures to extirpate the diseased mucosa [26]. In 1988, Sarti et al. [34] reported a case of paranasal sinus aspergillosis that exhibited expansion into the anterior cranial fossa and sella turcica. The patient was treated with a craniofacial resection, and unfortunately died secondary to a pulmonary embolus in the postoperative period. However, on fi nal pathological examination, no evidence of tissue invasion was noted. Numerous studies have subsequently shown AFRS to be a separate clinical entity from invasive fungal rhinosinusitis and have implicated atopy as one of the causative factors. Manning and Holman [23] showed that in vitro and in vivo allergy to fungal antigens were important to the pathophysiology of AFRS and that the predominance of eosinophil-derived infl ammatory mediators in in vivo tissue specimens diff erentiated AFRS from other forms of chronic rhinosinusitis. These studies gave further credence to the fact that AFRS is an immunological disease rather than an entity on the spectrum of infectious/invasive fungal disease. The change in mindset from invasive disease to immunologically based disease has altered the treatment algorithms for AFRS from that of extensive surgery and antifungal therapy to mucosa-sparing surgery with adjunctive corticosteroids [25].

AB - The term allergic fungal rhinosinusitis (AFRS) has been used to describe a clinicopathological entity characterized by: Nasal polyposis Crust formation Atopy Sinus cultures with fungus present Lack of tissue invasion on pathological analysis [25] Safi rstein [33] fi rst recognized the similarity between this entity and allergic bronchopulmonary aspergillosis in 1976. Since that time, a great deal of research has been devoted to the understanding, pathophysiology, and treatment of this disease. Despite these eff orts, a large number of questions still remain unanswered and serve as the nidus for future clinical research. The presence of fungus within the paranasal sinuses has a broad range of ramifi cations, ranging from the benign presence of saprophytic fungal growth to invasive fungal rhinosinusitis. The presence of fungus on cultures, the AFRS hallmarks of bony expansion, and radiological evidence of invasion led many clinicians to believe that AFRS was an early stage on the spectrum of invasive fungal rhinosinusitis [12, 25]; hence, an aggressive surgical stance was adopted as the primary mode of management of AFRS. Mc-Guirt and Harrill [30] stated in 1979, "Without question, the treatment of paranasal sinus aspergillosis is surgical-the key to successful surgical treatment is the removal of diseased mucosa and aeration and drainage of the involved sinus." Such evidence urged surgeons to perform radical surgeries such as lateral rhinotomies, craniofacial resections, and facial degloving procedures to extirpate the diseased mucosa [26]. In 1988, Sarti et al. [34] reported a case of paranasal sinus aspergillosis that exhibited expansion into the anterior cranial fossa and sella turcica. The patient was treated with a craniofacial resection, and unfortunately died secondary to a pulmonary embolus in the postoperative period. However, on fi nal pathological examination, no evidence of tissue invasion was noted. Numerous studies have subsequently shown AFRS to be a separate clinical entity from invasive fungal rhinosinusitis and have implicated atopy as one of the causative factors. Manning and Holman [23] showed that in vitro and in vivo allergy to fungal antigens were important to the pathophysiology of AFRS and that the predominance of eosinophil-derived infl ammatory mediators in in vivo tissue specimens diff erentiated AFRS from other forms of chronic rhinosinusitis. These studies gave further credence to the fact that AFRS is an immunological disease rather than an entity on the spectrum of infectious/invasive fungal disease. The change in mindset from invasive disease to immunologically based disease has altered the treatment algorithms for AFRS from that of extensive surgery and antifungal therapy to mucosa-sparing surgery with adjunctive corticosteroids [25].

UR - http://www.scopus.com/inward/record.url?scp=84892107222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892107222&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-34020-1_11

DO - 10.1007/978-3-540-34020-1_11

M3 - Chapter

AN - SCOPUS:84892107222

SN - 9783540340195

SP - 111

EP - 117

BT - Rhinologic and Sleep Apnea Surgical Techniques

PB - Springer Berlin Heidelberg

ER -